SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-036729
Filing Date
2022-12-28
Accepted
2022-12-28 21:45:50
Documents
1
Period of Report
2022-12-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3943
  Complete submission text file 0001493152-22-036729.txt   5437
Mailing Address C/O BIOPHARMX CORPORATION 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address
Krammer Anja B (Reporting) CIK: 0001418077 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39796 | Film No.: 221496232

Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Issuer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus